RPMI 8226 - CCL-155 - ATCC
网页RPMI 8226 are B lymphocytes isolated in 1966 from the peripheral blood derived from a 61-year-old, male, plasmacytoma patient. RPMI 8226 can be used in immunology and immune system research.
The surfaceome of multiple myeloma cells suggests potential ...
网页2022年7月15日 · A Correlation in surface proteomic profile between acute Btz treatment in RPMI-8226 cells (7.5 nM, 48 h, n = 3 biological replicates) vs. DMSO (n = 4 biological replicates) and aggregate BtzR...
Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 …
网页2020年10月22日 · Due to a variable pharmacology between the six HMCL, we utilized RPMI-8226 as a model to understand the potential of P2X7 receptor signaling in myeloma biology. RPMI-8226 expresses a pharmacologically sensitive P2X7 receptor and is also a common model of MM biology in vitro.
Pharmacodynamic, pharmacokinetic, and phase 1a study of
网页2021年8月2日 · In RPMI-8226 and MM.1S cell xenograft mouse models, oral administration of bisthianostat (50, 75, 100 mg·kg-1·d-1, bid) for 18 days dose dependently inhibited tumor growth.
Cell line: RPMI-8226 - DSMZ
网页Cell line name RPMI-8226. Species Homo sapiens (human) Cell type multiple myeloma. Incubation medium 90% RPMI 1640 + 10% h.i. FBS. Morphology cells grow mostly as single cells in suspension, some cells may grow adherent (occasionally up to 50%) Tumour type Multiple myeloma, plasma cell leukemia. RNA-seq project LL-100.
Cellosaurus cell line RPMI-8226 (CVCL_0014)
网页Doubling time: 60 hours (PubMed=25984343); ~60-70 hours (DSMZ=ACC-402); 33.5 hours (NCI-DTP=RPMI-8226). Microsatellite instability: Stable (MSS) (Sanger). Omics: Array-based CGH.
Cellosaurus cell line RPMI-8226/LR-5 (CVCL_J434)
网页Cellosaurus RPMI-8226/LR-5 (CVCL_J434) Population: African American. Characteristics: Produces IgG lambda (from parent cell line). Selected for resistance to: ChEBI; CHEBI:28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran). Omics: Transcriptome analysis by microarray.
RPMI-8226 | Cell - PubChem
网页Cell information for RPMI-8226. Find diseases associated with this biological target and compounds tested against it in bioassay experiments.
Acquired Resistance to Bortezomib in Human RPMI-8226 …
网页2008年11月16日 · In the present study we investigated whether chronic exposure to BTZ could provoke acquired resistance to BTZ in the human RPMI-8226 MM cell line model and whether a PSMB5 gene mutation would be responsible.
Combinatorial targeting of multiple myeloma by complementing T …
网页2021年1月8日 · This effect of hemibody-induced myeloma cell lysis was validated and verified on three further myeloma cell lines (OPM-2, RPMI-8226, and U-266; Fig. 3b).
- 某些结果已被删除